Recorded fact · drug.label_indication
drug.label_indication for cyclosporine|psoriasis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 4a597f91 resolves to.
The record
| Fact id | 4a597f911a93163e57403ca2 |
|---|---|
| Entity | drug: cyclosporine|psoriasis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20251204 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Psoriasis Cyclosporine capsules (modified) is indicated for the treatment of adult, nonimmunocompromised patients with severe (i.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 167fd5ce7037744c428d3fcf9f66b8bc591423ac4fac79bba7fbb2dece8d7029.
The value
{
"ingredient": "Cyclosporine",
"conditionId": "psoriasis",
"conditionName": "Psoriasis",
"matchedAlias": "Psoriasis",
"context": "indication",
"brand": "CYCLOSPORINE",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "1952d4c7-a40e-4924-b669-c41400774cb9",
"labelEffectiveTime": "20251204",
"labelsRead": 24,
"labelsNaming": 8,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 0ada9d3a4be703d5d57b3ca0731f3a7e92e0bee3a3ac5526c8cdb191a19ba531.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.